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GuillaineBarre syndrome is a rare neurological manifestation associated with dengue infection. More
common antecedent infections include Campylobacter jejuni and Cytomegalovirus infection. Here, we
report two cases of GuillaineBarre syndrome complicating dengue infection.
Copyright © 2015, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Dengue fever is a mosquito-borne infection caused by an
arbovirus and transmitted by Aedes mosquitoes. It is endemic in
Malaysia with an increasing number of cases reported every year
[1]. In 2009, the World Health Organization included neurological
manifestations as one of the diagnostic criteria for severe dengue,
recognizing the importance of neurological involvement in dengue
infection [2]. These neurological manifestations can be sub-
categorized into encephalopathy, encephalitis, immune-mediated
syndromes, dengue muscle dysfunction, and neuro-ophthalmic
disorders [3].
GuillaineBarre syndrome (GBS) is an immune-mediated disor-
der characterized by acute areﬂexic paralysis with albuminocyto-
logic dissociation. Variants of GBS include acute inﬂammatory
demyelinating polyneuropathy, acute motor axonal neuropathy
(AMAN), acute motor sensory axonal neuropathy, and Miller Fisher
syndrome [4]. Patients with GBS can present with a wide spectrum
of clinical manifestations ranging frommild self-limiting disease tont of Internal Medicine, Fac-
ra Malaysia, 43400 Serdang,
8947 2585.
lief Tzu Chi Foundation. Publishedacute fulminant cases with respiratory paralysis [5]. Compared
with other infections such as Campylobacter jejuni and cytomega-
lovirus, dengue fever is an uncommon antecedent of GBS and only a
few cases have been reported [6e9]. Here, we report two cases of
dengue fever complicated by GBS.2. Case Reports
2.1. Case 1
A 35 year-old man presented with a history of fever, chills, and
rigors associated with nausea and vomiting for 4 days. He had no
abdominal pain or bleeding tendency. In addition, he complained of
bilateral lower limb weakness and had been unable to ambulate
since the onset of fever.
Upon arrival, his clinical parameters were stable. He was well
perfused with a capillary reﬁlling time of < 2 seconds and a good
pulse volume. Neurological examination revealed reduced distal
muscle power (3/5) on dorsi- and plantar ﬂexion bilaterally. The
lower limb reﬂexes were diminished with a downgoing Babinski
response. Sensation was diminished in both lower limbs, pre-
dominantly along the L4 and L5 dermatomes. There was no
involvement of sphincter reﬂexes or the upper limbs. Examination
of the abdomen and respiratory and cardiovascular systems
revealed no abnormalities.by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
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bin level with a hematocrit of 42.9%, thrombocytopenia (134  109/
L), and a normal white cell count. (4.27  109/L). His renal function,
liver function, serum electrolytes, and creatine kinase were within
the normal ranges. Dengue nonstructural protein-1 antigen was
positive. A lumbar puncture was deferred as the patient did not
consent to the procedure. A subsequent nerve conduction study
(NCS) was consistent with axonal motor polyneuropathy affecting
both lower limbs.
A diagnosis of GBS complicating dengue fever was made and he
was treated accordingly. He was monitored closely for ascending
weakness and respiratory muscle involvement. As his neurological
deﬁcit was mild, he did not receive any form of immunotherapy. He
recovered from the acute illness and was discharged with residual
weakness in ankle joint movement bilaterally. He was referred for
further physiotherapy and occupational therapy. At the 3-month
follow-up, there was marked improvement of muscle power and
he was able to walk without aids.
2.2. Case 2
A 52 year-old man presented with progressive, ascending
weakness of both lower limbs for 3 days. He had no facial asym-
metry, slurred speech, or dysphagia. No sphincter involvement was
noted. He had been discharged from the hospital 1 week previously
for dengue fever which was nonstructural protein-1 antigen posi-
tive. Upon examination, his vital signs were stable. His peak expi-
ratory ﬂow rate was 360 mL/min. Neurological examination
revealed severe weakness of the lower limbs, and he was unable to
move either of his lower limb muscle groups against gravity.
Patellar reﬂexes were absent but sensation was intact. His upper
limbs were weak over the distal muscles with areﬂexia. Examina-
tion of the cranial nerves was normal. Examination of the cardio-
vascular and respiratory systems showed no abnormalities. Initial
laboratory investigation revealed a hematocrit of 50%, and normal
leucocyte and platelet counts. The renal proﬁle was normal but
liver function tests showed mild transaminitis (alanine trans-
aminase 111 IU/mL).
A lumbar puncture was performed and cerebrospinal ﬂuid (CSF)
examination revealed albuminocytologic dissociation consistent
with a diagnosis of GBS (Table 1).
He was started on a 5-day course of intravenous immunoglob-
ulin (IVIG) 400 mg/kg/d. He was closely monitored for progression
of disease, especially respiratory muscle involvement. On his 4th
hospital day, his condition deteriorated and he developed respira-
tory muscle paralysis requiring mechanical ventilation. Unfortu-
nately, his condition was further complicated by episodes of healthTable 1
Clinical features and investigations for patient 1 and patient 2.





Clinical presentations Bilateral lower
limbs weakness
Progressive ascending weakness
















Clinical outcome Good recovery Dead (due to ventilator-associated
pneumonia)
CSF ¼ cerebrospinal ﬂuid.care-associated infection and multiorgan failure. He died after 3
weeks in the intensive care unit.
3. Discussion
Dengue fever is a common mosquito-borne infection in tropical
and subtropical countries and has a wide spectrum of clinical
manifestations. The association between dengue fever and neuro-
logical manifestations is relatively uncommon. Only 1e5% of
dengue cases were reported to have neurological involvement [10].
The two most common neurological complications of dengue are
encephalopathy and encephalitis. Other manifestations include
myelitis, myositis, GBS, and polyneuropathy [11]. Dengue has four
distinct but closely related serotypes (DEN-1, DEN-2, DEN-3, and
DEN-4). Of these, DEN-2 and DEN-3 are the most frequently re-
ported serotypes in association with severe neurological disease
[11].
GBS has an incidence of 0.6e1.9 per 100,000 population. It is
characterized by ascending paralysis, areﬂexia, and sensory
changes [6]. It is the most common peripheral nervous system
complication of dengue fever, and is usually reported during the
recovery phase of the illness [12]. AMAN is a rare variant of GBS
classiﬁed based on NCS [4]. There are numerous case reports and
case series on dengue with GBS. A wide spectrum of clinical man-
ifestations are documented, ranging from mild motor weakness to
debilitating quadriparesis and respiratory weakness requiring
mechanical ventilation [9,13]. Therefore, high clinical suspicion is
important to identify patients with GBS complications.
Our ﬁrst patient developed symmetrical bilateral lower limb
weakness at the onset of dengue fever. This is relatively uncommon
as in most reported cases the onset of weakness was 1 week after
dengue infection [3]. There was no ascending weakness and he
improved clinically prior to discharge. The second patient had a
more severe disease progression with debilitating quadriparesis
and subsequent respiratory muscle paralysis requiring prolonged
mechanical ventilation complicated by sepsis. The onset of muscle
weakness was 5 days after the acute illness. These two cases
demonstrate the two different ends of the clinical spectrum of GBS
complicating dengue infection (Table 2). The close relationship
between dengue and the onset of GBS strongly suggests that
dengue is a preceding infection. In patients with such pre-
sentations, other diagnoses need to be excluded, such as hypoka-
lemic paralysis and acute myopathy. These two diagnoses were
unlikely as the patients had normal serum electrolyte and creatine
kinase levels.
The essential investigations in GBS include lumbar puncture and
NCS. CSF analysis might show increased protein concentration
without pleocytosis (albuminocytologic dissociation), while NCS
will show features consistent with demyelinating polyneuropathy
[4]. Although a lumbar puncture was not performed in our ﬁrst
patient, NCS supported the diagnosis of AMAN with reduced con-
duction affecting both lower limbs. CSF analysis in our second pa-
tient was consistent with the diagnosis of GBS.
The mainstay of treatment in GBS is plasmapheresis and IVIG.
Corticosteroids have been proven ineffective as reported in several
studies [14]. When treatment is initiated within 2 weeks of diseaseTable 2




White cell count 0 cells/mL
Culture Negative
́Y.L. Boo et al. / Tzu Chi Medical Journal 28 (2016) 157e159 159onset, IVIG is reported to be as effective as plasma exchange in
patients with GBS who cannot walk independently [15]. Compli-
cations such as autonomic dysfunction, sepsis, and deep vein
thrombosis need to be treated aggressively during the progress of
the disease [4]. The ﬁrst patient presented with mild disease, and
thus, no treatment was initiated. There was no progression of dis-
ease after admission and he recovered with minimal deﬁcits
following rehabilitation. By contrast, the second patient was started
on immunotherapy upon diagnosis due to the severity of the
illness. However, he later developed respiratory muscle paralysis
and required mechanical ventilation. Unfortunately, he died.
The prognosis of GBS is generally favorable, but it is associated
with mortality in approximately 10% in patients with severe dis-
ease, especially when there are complications from prolonged
ventilation [14]. Recognizing complications, especially respiratory
failure, is important for early intervention to reduce morbidity and
mortality in severe disease. Despite immunotherapy and optimal
support, around 20% of patients develop long term disability [16].
4. Conclusions
Dengue fever remains a serious global public health problem.
Although it is rare, GBS should be as a differential diagnosis when
patients present with weakness after dengue infection. With the
surge of dengue cases, awareness of this condition is extremely
crucial to reduce the morbidity and mortality.
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